Drugs / Autologous Nanofat Injection
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT07679217 Comparator | Jun 2026 → Jun 2027 expected | skin atrophy | Tanta University | Enrolling by invitation | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous Nanofat Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07679217 ↗ |
| Modality | Other / unclassified | “autologous nanofat grafting, which is rich in adipose-derived regenerative cells and growth factors” NCT07679217 ↗ |